AXM Pharma Announces the Appointment of a New Chief

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
191
AXM Pharma Announces the Appointment of a New Chief Executive Officer

NEW YORK, July 03, 2018 (GLOBE NEWSWIRE) -- AXM Pharma, Inc. (OTC:AXMP) (“AXM Pharma” or the “Company”) is pleased to announce that its Chairman, Mr. Emmanuel Neossi, has appointed Linda L. Forster as the new Chief Executive Officer effective immediately. As announced on July 2, 2018 Mandla J. Gwadiso resigned as our Chief Executive Officer, Chief Financial Officer, President, Director, Secretary, and Treasurer. The resignation was not the result of any disagreement with us on any matter relating to our operations, policies or practices. On June 25, 2018, Mr. Emmanuel Neossi was appointed as our new Chairman of the board of directors.

Emmanuel Neossi, Chairman of AXM Pharma, stated, “We are thrilled to have Mrs. Forster join us as the new Chief Executive and we look forward to her contribution that will lead us to becoming a fully reporting company, as we seek to up-list to the OTCQB and ultimately the Nasdaq.” 

Linda L. Forster, Chief Executive Officer of AXM Pharma also stated, “I am happy to join Emmanuel and his team and be part of what will ultimately become a world renowned cocoa producer, distributor and marketer. It won’t be easy, but we as a team will give our best to ensure that our shareholders see good returns on investment.”

Linda L. Forster, Age 49, Chief Executive Officer

Linda Forster is a seasoned Management expert with more than 20 years of management experience, including human resources management and operations; training and development, Linda’s management style has a proven ability to effectively make firm decisions that centre on business growth.

Prior to joining AXM Pharma, Inc., Linda Forster was the Co-Founder, President & CEO of Forster Company. Forster Company is a professional services corporation headquartered in Los Angeles, California specializing in all phases of construction related activities, including: Project Management and Construction Management and Community Relations. Linda has successfully managed over two billion dollars of construction projects. 

In addition, Linda practices intentional civility and has a collective conscious.  She has been actively involved in serving the community by virtue of her participation on various committees and commission boards including Los Angeles City, Los Angeles County, and California State Commissions.

A graduate of California State University Long Beach, Mrs. Forster holds a Master of Social Work (MSW). She earned her Bachelor of Arts in Sociology from Pepperdine University located in Malibu, California.

About AXM Pharma, INC.

AXM Pharma, Inc. The Group's principal activity is to sell over-the-counter and prescription pharmaceutical products in The People's Republic of China. The products are currently produced by third-party manufacturers and sold through third-party distributors. On 01-Jul-2006, the Group acquired 51% equity interest in Liaoning Ming Cheng Medical & Pharmaceutical Co., Ltd.

About ASIC.

ASIC is a Cameroon-based holdings company which fully owns the largest indigenous cocoa trading company in Cameroon, as well as a state of the art cocoa processing company, with headquarters in Kekem. ASIC has several drying and storage units in Kekem, Douala or other rural areas in the centre region. In a few years of activity, ASIC through its strong network of producers, producer groups and business partners such as Touton SA, Sucden, Olam International has established itself as one of the leaders in cocoa / coffee trading in Cameroon.

The management team of ASIC is made up of skilled professionals, each having several years of experience such as its CEO Mr. Emmanuel Neossi who has 20 years of experience in the cocoa trade area.

Cautionary Note:

The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

For more information: 
Tel:+1-212-709-8206
Fax:+1-212-943-2300

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

TRIMEDX Earns Spot in 2024 Inspiring Workplaces Rankings

Updated Category News Views 62

TRIMEDX Recognized as One of the Top Inspiring Workplaces TRIMEDX, a leading name in clinical asset management, has proudly claimed the 30th spot on the 2024 Global Top 100 Inspiring Workplaces list. This esteemed recognition highlights organizations that prioritize people-first practices and create outstanding workplace environments. A Global Overview The Inspiring...

Continue Reading
Triumvirate Environmental Secures Major Investment Boost

Updated Category News Views 326

Triumvirate Environmental Announces $1.8 Billion Valuation Triumvirate Environmental, a prominent name in environmental services, has recently received a significant growth investment from Berkshire Partners, a well-respected private equity firm. This monumental partnership has led to Triumvirate being valued at $1.8 billion, a testament to its strong market position and...

Continue Reading
Investing in MSCI: A Journey Over 15 Years Explained

Updated Category News Views 198

The Growth of MSCI Over 15 Years MSCI (NYSE: MSCI) has demonstrated impressive performance over the past decade and a half, significantly outperforming the market. With an annualized return of 20.17%, MSCI has amassed a market capitalization of $43.82 billion. This remarkable performance speaks volumes about the company’s solid market positioning and timely strategic...

Continue Reading
Deckers Outdoor Surges in Premarket Trading After Strong Earnings Report

Updated Category News Views 243

Deckers Outdoor Impresses with Strong Financial Results Shares of Deckers Outdoor Corporation (NYSE: DECK) have recently experienced a notable increase in value. This uplift can be attributed to the company's impressive second-quarter earnings, which surpassed analysts' expectations. The casual footwear and apparel retailer reported revenue of $1.31 billion, significantly...

Continue Reading
Vitrolife Group Secures Major Financing Through Nordic Banks

Updated Category News Views 190

Vitrolife AB Strengthens Financial Backbone Vitrolife AB (publ) has taken a significant step towards enhancing its financial foundation by renewing and signing a loan agreement worth EUR 300 million. This strategic financial maneuver includes both a term loan and a revolving credit facility, aimed at refinancing existing debt while also providing resources for general...

Continue Reading